OR WAIT null SECS
Pharmaceutical Technology
Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.
November 17, 2014
Pfizer will pay $850 million upfront and as much as $2 billion later in a deal to jointly develop one of Merck?s cancer drugs.
Avastin plus chemotherapy for the treatment of ovarian cancer increased progression-free survival by 62% compared with chemotherapy alone.
The transaction provides Allergan stockholders with immediate value and enhanced commercial opportunities, according to a company statement.
After being plagued by numerous delays, Lemtrada (alemtuzumab) has finally been approved by FDA for the treatment of multiple sclerosis.
November 07, 2014
ANSM wants company data on the benefits and risks of using Avastin over Lucentis in the treatment of wet age-related macular degeneration.
November 06, 2014
The deal between the two companies will strengthen Perrigo's presence in Europe.